I think they are quite similar. Some of the implementation issues are also similar to what we heard in the initial information sessions. We are going to be meeting with Dr. Vivek Goel next week to go over things in detail.
We've talked a little about security clearance. We're going to have a concerted look at trying to harmonize and not duplicate efforts in the program design and regulations.
I think there's also some anxiety about not having bottlenecks in security clearance, for example. On the one hand, having the federal government shoulder the cost of security clearance is a plus point, but there is anxiety around whether they can process them fast enough. We need to look at the security clearance program itself, with the stakeholders as well, to see what is acceptable, feasible, and reasonable.
Regarding the issue of the power of the Minister of Health, while it's essentially on par with the usual legal language in a bill, we wanted to reassure the provinces and territories that there are limits. The minister can have information disclosed or exercise the powers in the bill only if it pertains to the act itself. On the two other conditions, certain information can be disclosed if there is imminent danger or a public safety incident, or if there are international reporting requirements, such as the international health regulations. So there are some very specific boundaries pertaining to those powers.
I don't know if Jane has anything to add on that.